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The Role of Glutathione in Detoxication
by Brian Ketterer,* Brian Coles* and David J. Meyer*
Glutathione (GSH) is a strong nucleophile which reacts well with soft electrophiles, but poorly
with both weak and strong electrophiles. Weak electrophiles have low reactivity with all
nucleophiles while strong electrophiles react well with weak nucleophiles including superabundant
H20.
There are enzymes, the GSH transferases, which catalyze GSH conjugation with all the types of
electrophiles described above. In order to deal with the wide variety of potential substrates, a
multiplicity of GSH transferases exists-each tissue having its own collection and each enzyme
having a different substrate specificity. These enzymes are often very abundant, e.g., in the rat liver
cytosol, their concentration is 0.2 mM.
The following substrates are considered in some detail: 1-chloro-2,4-dinitrobenzene, the electro-
phile derived metabolically from paracetamol N-acetyliminoquinone?), benzo(a)pyrene-4-5-oxide,
cholesterol-5a,6a-oxide, benzo(a)pyrene-7,8-diol-9,10-oxide and the electrophiles derived metaboli-
cally from aflatoxin B, (the 2,3-oxide?). According to the substrate, optimal enzyme rates vary over
seven orders of magnitude from 10-1 to 10-12 mole/min/mg.
Despite the wide embrace of the GSH transferases, not all metabolically produced electrophiles
are substrates. We know of the following examples: N-methylol-4-aminoazobenzene and its 4'-
hydroxy derivative (these are soft electrophiles and react well with GSH noncatalytically), N-sul-
fonyloxy-N-methyl-4-aminoazobenzene, N-sulfonyloxy-N-acetyl-2-aminofluorene (these are strong
electrophiles which do not react selectively with GSH) and N-hydroxy-2-aminofluorene which ap-
pears to react only slowly with GSH. It is of interest in the present context that all these compounds
are derived from either arylamine or arylamide carcinogens.
Whether the reaction be enzymic or nonenzymic, conjugation with GSH is a very important means
of detoxication accounting in some cases for up to 60% of the biliary metabolites. As seen in the ex-
ample of aflatoxin B,, very low enzymic rates observed in vitro are sufficient to account for appar-
ently high rates of biliary excretion of GSH conjugates.
GSH transferases have evolved other functions apart from the catalysis of GSH conjugation. GSH
transferase B participates in the hepatic uptake of bilirubin and the intracellular distribution of the
heme prosthetic group. It also has GSH peroxidase activity which suggests that it might participate
in the detoxication of by-products of oxygen utilization including those produced by the action of cy-
tochrome P-450. It is shown that GSH transferase B inhibits lipid peroxidation in vitro.
Glutathione
Glutathione (GSH), y-glutamylcysteinylglycine, is
a molecule with the following important properties.
Its cysteinyl residue provides a nucleophilic thiol
important for the detoxication of electrophilic me-
tabolites and metabolically produced oxidizing
agents. Its net negative charge and overall hydro-
philicity greatly increases the aqueous solubility of
the lipophilic moieties with which it becomes conju-
gated. Its molecular weight (307) ensures that its ad-
ducts are preferentially secreted via the biliary
system which selects molecules of molecular weight
greater than 300 to 500 according to the species (1).
Its unique tripeptide structure, including the N-ter-
minal glutamyl residue linked via a y-glutamyl pep-
tide bond, provides for specificity in GSH-enzyme
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interaction. It is apparently universal in nature, of-
ten at high intracellular concentrations, e.g., in the
rat liver it is 5-10 mM (2), while glucose is 5 mM,
ATP 3 mMand ascorbic acid and alanine 2 mM(3).
Conjugates
In mammals, GSH conjugates are often further
metabolized by hydrolysis and N-acetylation, either
in the gut or in the kidney, to give N-acetylcystein-
yl conjugates known as mercapturic acids, which
are excreted in the urine (4). It might be asked why
conjugation with cysteine does not occur in the first
place. Presumably GSH provides a means whereby
the pool of cysteine for detoxication is kept separate
from the pool of cysteine for protein synthesis.
Factors Affecting GSH Conjugation
Nucleophilic Character of GSH. GSH exists as
two nucleophilic species at physiological pH, GSHKETTERER, COLES AND MA YER
and its thiolate anion. Concentrations of the latter,
the stronger nucleophile, are approximately 1% of
GSH concentration [pKa of GSH = 9.2 (5, 6)].
Nature of Electrophilic Center. Reactions with
which we are mostly concerned are nucleophilic sub-
stitutions (including opening of the strained oxirane
ring) and nucleophilic additions to a polarized double
bond. The mechanism of GSH conjugation may be
examined in relation to the two following extremes.
(a) The electrophilic center is soft, and the nucleo-
phile initiates reaction by causing polarization of the
electrophile: in these circumstances strong nucleo-
philes such as GSH and GS will react best. (b) The
electrophilic center is hard and capable of initiating
reaction by generation of polarization in a weak
nucleophile and therefore reaction is less dependent
on GSH.
Glutathione Transferases
Numerous xenobiotics have been shown to be ex-
creted as mercapturic acids (4), and it has been sug-
gested that enzymes, the GSH transferases, cata-
lyze the initial conjugation with GSH (7). It will be
shown below that enzymic catalysis is not always in-
volved in GSH conjugation; nevertheless, GSH
transferases are widespread in both animals and
plants (8). They appear to have evolved later than
GSH itself, but are found in animals as primitive as
the flatworm (9). In a highly evolved animal such as
the rat, the organism as a whole has a multiplicity
of GSH transferases (10). All tissues appear to pos-
sess some activity; most have more than one en-
zyme species -usually a spectrum of isoenzymes
which is characteristic of the tissue (11, 12). The
multiplicity of GSH transferases is probably due to
the need to deal with a large range of electrophiles.
However, it is not clear what the electrophiles en-
countered by various tissues are, although it is as-
sumed that in the liver, which is so important in de-
toxication, most of the electrophiles are derived
from xenobiotics.
Detoxication by Glutathione
in the Rat Liver
In the present paper we will concentrate on de-
toxication by GSH and GSH transferases from the
rat liver, the area which has been the object of most
of our researches. The detoxication of arylamines
and arylamides will be compared with that of other
compounds.
Rat Liver Glutathione Transferases
Occurrence. The greatest source of GSH trans-
ferases is the cytosol, where the concentration may
range from 0.2 to 0.5 mM (13), according to whether
or not the transferases have been induced by
agents such as phenobarbitone, BHA, TCDD, etc.
(14-16). Other GSH transferases have been detected
in the membrane of the hepatic microsomes and the
mitochondria (17-19).
Structure and Function. The soluble isoenzymes
number at least seven, each with a similar dimeric
structure in which the monomers fall into three
categories defined by their apparent molecular
weights as ya (MW 22,000), Yb (MW 23,500) and Y,
(MW 25,000) (20). GSH transferases A, C, D (?) and E
are all homodimers of Yb, but vary in their isoelec-
tric points and substrate specificities, indicating
that the monomer referred to as Yb represents
more than one polypeptide (21). GSH transferase
AA is a Y. homodimer, while GSH transferase B is
separable into two forms, one of which is a Ya homo-
dimer yaya and the other a heterodimer YaYc (20,
22) (Figs. 1 and 2). GSH transferase AA and the two
forms of GSH transferase B can be grouped to-
gether because of their possession of GSH peroxi-
dase activity (23) and similarities in the structures
of Ya and Ye which have at least two-thirds of their
amino acid sequences in common despite the
greater molecular weight of the latter monomer
(24). There is, however, one important difference be-
tween Ya and Ye. Ya' in addition to its enzymic
properties, possesses a high affinity binding site for
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FIGURE 1. Separation and subunit compositions of GSH
transferases from rat liver soluble supernatant fraction:
(A) the GSH transferase fraction is separated by gel chro-
matography on Sephadex G100 and submitted to
isoelectric focusing; (B) the fraction focusing at pH 9-10 is
then separated further on CM cellulose in 10mM
phosphate pH 6.7 using a 0-0.2Mgradient; (C) the subunit
composition of the various GSH transferases is shown by
sodium dodecyl sulfate polyacrylamide gel electrophoresis.
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benzo (a) pyrene-4,5-oxide
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benzo (a) pyrene-7,8-diol-9, 10-oxide
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FIGURE 2. Substrate specificity of two BP-oxides towards
GSH transferases separated by isoelectric focusing as in
Fig. 1. The ordinate indicates both pH gradient and en-
zyme activity (the scale for BP-4,5-oxide is three orders of
magnitude greater than that for BP-7,8-diol-9,10-oxide)
(Table 1).
compounds with lipophilic moieties (25, 26): this
property defines GSH transferase B, otherwise
known as ligandin (27).
To say that there are seven GSH transferases in
the rat liver is a conservative estimate. There is
heterogeneity in Yaya (24) and also GSH transferase
A (a Yb dimer), both of which give two isoelectric
forms. It is probable that all these variations, large
and small, in GSH transferases are adaptations
which enable interaction with the wide range of
substrate structures which it is assumed hepatic
GSH transferases are required to detoxify. The evo-
lution of a high affinity binding site which character-
izes Ya has been shown to be important for a
number of nonenzymic functions, e.g., the hepatic
uptake of bilirubin (28, 29), the release of mitochon-
drial heme for utilization in the hepatocyte (30) and
also, according to a mathematical model of the hepa-
tocyte, the uptake and intrahepatocellular transport
of lipophilic substrates (13).
Combined Catalytic and Noncatalytic Conjugation
with GSH. A number of electrophiles undergo
GSH conjugation by substitution or addition reac-
tions at appreciable noncatalytic rates. Many, but
not all, such reactions are also catalyzed by GSH
transferases.
Where both catalytic and noncatalytic reactions
occur, it is of interest to assess what the relative im-
portance of these two reactions might be in vivo,
but little of the necessary data is available. Data are
available for the conjugation of 1-chloro-2,4-dinitro-
benzene (CDNB) (an extremely useful substrate
used in the laboratory to identify and quantitate
GSH transferase activity since unlike other electro-
philes it is a good substrate for many GSH trans-
ferases; see Table 1) and GSH. In using them it is
necessary to assume that kinetic data obtained in
vitro can be applied to the intrahepatocellular
milieu. There the concentration of GSH transferases
is known to be high, at least 0.2 mM, and aqueous-
Table 1. GSH transferase activity.
GSH transferase activity, jmole substrate
conjugated/mg enzyme/mina
Substrate B AA A C E Reference
1-Chloro-2,4-dinitrobenzene 11 14 62 10 0.1 (7)
1,2-Dichloro-4-nitrobenzene 3 x 10-3 8 x 10-3 4.3 2 0 (7)
Ethacrynic acid 0.26 0.30 0 0.1 0 (7)
trans-4-phenyl-3-buten-2-one 1 x 10-3 - b 20 x 10-3 0.4 0 (7)
Benzo(a)pyrene-4,5-oxide 11 x 10-3 4 x 10-3 90 x 10-3 100 X 10-3 70 x 10-' (38)
Cholesterol-5a, 6a,-oxide 100 x 10-6 b b b b (71)
Aflatoxin B,-2,3-oxidec 30 x 10-' - b 3 x 10-6 9 x 10-' b (50)
Benzo(a)pyrene-7,8-diol-9,10-oxide 0.7 - b (0.2)d (0.3)d (1.2)d (72)
a GSH transferase activity is expressed as j,mole substrate conjugated per mg enzyme per minute under varying conditions.
They do not necessarily represent Vmax.
b Not determined.
c The reactive metabolite so marked is a postulated rather than a proven structure.
d Rough estimates based on competition for the reactive metabolite by the GSH transferase in question and DNA.
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free concentrations of lipophiles such as CDNB are
assumed to be low, owing to the presence of abun-
dant membrane lipid into which most of the CDNB
will partition. Low substrate concentration and high
enzyme concentration will ensure that the contri-
bution of the noncatalytic rate will be small. Using
data for GSH transferase B only and assuming an
intracellular concentration of GSH to be 10 mM, we
calculate that the contribution of the noncatalytic
rate is only 0.01% of the total rate (31, 32). In tis-
sues in which the lipid fraction is not so abundant
and the enzyme activity is low, the contribution of
the noncatalytic reaction might be expected to be
higher.
However, the principal role of hepatic GSH trans-
ferases is to detoxify electrophiles produced meta-
bolically. The intracellular-free concentration of elec-
trophiles generated in vivo by enzymes with slow
rates such as the mixed function oxygenases is
likely to be low and, therefore, by analogy with
CDNB the contribution of the noncatalytic reaction
to the total will be negligible. Mathematical models
set up to describe these systems support this con-
clusion (33).
GSH Conjugation of Electrophilic
Species Formed In Vivo
The Reactive Metabolite of Paracetamol
Paracetamol is believed to be oxidized at the en-
doplasmic reticulum to N-acetyliminoquinone, which
undergoes nucleophilic addition of GSH followed by
rearrangement to give 3[glutathion-S-yl]paraceta-
mol (Fig. 3). (34). This reaction proceeds well both
noncatalytically as well as catalytically (35), but on
the basis of the above discussion the noncatalytic
contribution in vivo should be negligible (33). Pre-
liminary results suggest that the reactive metabo-
lite of paracetamol is a better substrate for GSH
transferases A and C than for GSH transferase B
(36).
HNCOCH3
0-i->
OH
unreactive towards GSH (it is a soft and weak elec-
trophile) yet GSH conjugation is catalyzed quite ef-
fectively by GSH transferases (37-39). A comparison
of the purified GSH transferases shows that BP4,5-
oxide is a much better substrate for GSH trans-
ferases A and C than for B and E (Table 1 and Fig.
2) (38).
BP-7,8-diol-9,10-oxide
BP-7,8-diol-9,10-oxide (Fig. 2), the ultimate carcino-
gen of BP (40, 41), is the opposite of BP4,5-oxide in
that it is highly reactive and compared with CDNB
is a much harder electrophile capable of reacting
rapidly with weak nucleophiles, including water.
The amount of noncatalytic reaction with GSH at
physiological concentrations is negligible; neverthe-
less, in the presence of GSH transferases, GSH con-
jugation occurs (41). In contrast to BP4,5-oxide,
GSH transferases B and E are more effective cata-
lysts than GSH transferases A and C (41) (Table 1
and Fig. 2).
Cholesterol-5a,6a-oxide
Cholesterol-5a,6a-oxide is a suspected mutagen
which may be generated from endogenous
cholesterol during lipid peroxidation (42, 43).
Conjugation with GSH is catalyzed in vitro by
transferase B, but not by A or C (Table 1),
perhaps due to the hydrophobic site of transferase
B, which is known to bind cholesterol (44). Nonenzy-
mic reaction with GSH is negligible.
Aflatoxin B1-2,3-oxide (AFB1-oxide)
The ultimate carcinogen of AFB, (assumed to be
the 2,3-oxide) (45) formed by activation ofAFB, by a
liver microsomal fraction resembles BP-7,8-diol-9,10-
oxide in being a highly reactive strong electrophile
with a negligible noncatalytic reaction with GSH in
the absence of GSH transferases (46-48) (Fig. 4).
0 0 0
01
aflatoxi B, {A 2,OCH, 03 0
altxnB AFB,) AFB, -2. 3-oxide - - . 1
N - acetyl - iminoquinone
FIGURE 3. Activation and GSH conjugation of paracetamol
(34).
Benzo(a)pyrene4,5-oxide (BP4,5-oxide)
It is hard to judge as yet how typical the cases of
CDNB and N-acetyliminoquinone are. None of the
following cases conform with these examples. For
example, BP4,5-oxide (Fig. 2) is relatively stable and
3 - GS - paracetamol
0 0
HO
GS O 0o OCH3
AFBI
- SG
FIGURE 4. Activation and GSH conjugation of aflatoxin B,
(47).
paracetamol
-.-I--
ASH +
GSH transferase
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Data are not yet available for GSH transferase E,
but as with the above diol-epoxide GSH transferase
B is a much more effective enzyme than GSH trans-
ferases A and C (48) (Table 1).
Reactive Metabolites ofN,N-Dimethyl4-
aminoazobenzene (DAB)
Metabolism of DAB or N-methyl4-amino-
azobenzene (MAB) gives rise to two different types
of electrophile for which there is no evidence of an
enzyme-catalyzed GSH conjugation.
The N-methyl oxidation of MAB or 4'-OH-MAB
gives an intermediate which is a soft electrophile re-
acting readily with GSH and believed to be an N-
methylol or a methimine (49). GSH conjugation of
the intermediate derived from MAB gives N4gluta-
thion-S-methylene)4-aminoazobenzene (GSCH2AB)
(49) or, in the case of 4'-OH-MAB, 4'-OH-GSCH2AB
which is sulfated in vivo to 4'-sulfonyloxy-GSCH2AB
(50) (Fig. 5). In in vitro experiments involving the
microsomal oxidation of MAB in the presence of
GSH, the yield of GSCH2AB is directly proportional
to the GSH concentration in the incubation (49),
which is characteristic of a nonenzymic reaction.
The reaction is not dependent on the microsomal
GSH transferases which are present in the incu-
bation nor is it affected by added soluble GSH
transferases.
The other electrophile results from N-hydroxyl-
ation of MAB followed by sulfation. The resulting
N-sulfonyloxy MAB forms a highly reactive cation
which exists as the nitrenium ion and the 3, 2' and
4' carb.onium ions (Fig. 6) (51).
N-Sulfonyloxy MAB, unlike the other ultimate
carcinogens BP-7,8-diol-4-,5-oxide and AFB,-oxide
discussed above, is not a substrate for GSH
transferase B (52, 53). This is surprising, since GSH
transferase B or ligandin was first isolated as a pro-
tein that bound activated aminoazodye carcinogens
covalently (54, 55) and was subsequently shown to
have a noncovalent binding site for N,N-dimethyl-4-
aminoazobenzene (56) and 4-sulfonyloxyazobenzene
(57), which are structures related to the ultimate
carcinogen. Three of the four possible cysteinyl
residues per mole of GSH transferase B, YaYa react
covalently with a proportion of the N-sulfonyloxy-
MAB produced in vivo: similarly, three cysteinyl
residues in yaya also react with hydrophobic thiol
N - metl -mN bNz
N - methyl -4- aminoazobenzene (MAB)
4
=N=N-\H N\
H
HO N=N
'If
HO N=SG
H
4'- OH - GSCH2AB
-H20
+H20
HO N=N- N=CH2
GSH
+ N N H2ABH2SG
GSCH2AB
FIGURE 5. N-Methyl oxidation ofN-methyl-4-aminoazobenzene to generate N-methylol or methimine intermediates and their reac-
tion with GSH (50, 51).
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FIGURE 6. N-Oxidation of N-methyl-4-aminoazobenzene to generate the strongly electrophilic nitrenium and carbonium ions and
their reaction with GSH (53).
reagents such as p-chloromercuribenzoate and with-
out substantial loss of enzymn activity (22). It is
therefore possible thatN-sulfonyloxy MAB does not
orient at the enzyme surface in,a manner favorable
to GSH conjugation. If unfavorable orientation does
occur, it would appear to be a property shared by
both the soft and hard electrophilic metabolites of
MAB.
Although conjugation of N-sulfonyloxy-MAB is
noncatalytic in vivo, the product distribution of
GSH conjugates is more selective in vivo than in
vitro. Thus 3-GS-MAB, but neither 2'-GS-MAB nor
4'-GS-MAB which are formed in vitro, is found in
bile (52).
N-Acetyl-2-Aminofluorene (AAF)
Unlike DAB, AAF does not give rise to soft elec-
trophilic metabolites which react readily with GSH.
Like DAB, AAF gives a highly electrophilic N-
sulfonyloxy metabolite which is the ultimate carcin-
ogen (58, 59). Studies with the relatively stable N-
acetoxy-AAF (60) and more recently, N-sulfonyloxy-
AAF (61), show reaction with GSH to be poor and to
give rise to several conjugates, namely 1-, 3-, 4-, and
7-GS-AAF (Fig. 7). This reaction is not affected by
GSH transferases. Yet as with DAB the product
distribution of GSH conjugates is more selective in
vivo than in vitro. Only 1- and 3-GS AAF are found
in bile (60).
_$~ C ICOCH3 %
N-acetyl-2-aminofluorene (AAF) I
'
4
3 <
(
nitrenium ion N-
KN HIC~N COCH,
3- &1-carbonium ions
GSH
( \~~~~OH-
N-hydroxy-AAF
sultotransferase
< X _~~~~~I- sCOCH3
-sulphonyloxy- AAF
(- NI4H1 N COCH3
1,
SG
3-(glutathion-S-yl)- AAF 1-(glutathion-S-yl)- AAF
FIGURE 7. N-Oxidation of N-acetyl-2-aminofluorene to gener-
ate the strongly electrophilic nitrenium and carbonium
ions and reaction with GSH (60).
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The Question of Aminofluorene (AF) Adducts
AAF gives rise to both AAF and AF adducts to
DNA (62, 63). The electrophilic metabolite most
likely to bring this about is N-acetoxy-AF resulting
from enzymic transacetylation of N-OH-AAF (64).
Another possible electrophilic metabolite is N-OH-
AF resulting from N-deacetylation of N-OH-AAF
(62-64). N-OH-AF has been shown to react with GSH
in vitro to give N(glutathion-S-yl)AF (see Fig. 8) (66).
This reaction is relatively slow and not catalyzed by
GSH transeferases (65). A similar product might be
expected to be produced more rapidly by N-
acetoxy-AF; however, no such GSH conjugate is ob-
served in bile (65). If, as expected, electrophilic
derivatives of AF are generated in the cytoplasm,
their fate remains to be determined.
N ~~~~~/H
OH
N-hydroxy-2-aminofluorene
GSH slw
~~~N~~~H
-N / G~~ SG
N-(glutathion -s-yi)-2-aminofluorene
FIGURE 8. Reaction of N-hydroxy-2-aminofluorene with GSH
(65).
Quantitative Importance of GSH
Conjugation in Detoxication
The importance of GSH conjugation in the detoxi-
cation of a xenobiotic depends on the extent to
which the xenobiotic is metabolized to electrophiles.
In the case of DAB, soft electrophiles are pro-
duced in quantity which react noncatalytically with
GSH. Of the biliary metabolites, 60% occur as
GSCH2AB or 4'-sulfonyloxy GSCH2AB (50). Even the
ultimate carcinogen, N-sulfonyloxy MAB, which is a
hard electrophile, reacts noncatalytically with GSH;
it gives a conjugate accounting for 0.2% of the total
dose, which is two orders of magnitude higher than
binding to DNA (67). The competition between GSH
and DNA in vivo is much more in favor of GSH
than expected from in vitro experiments. Since
these reactions are noncatalytic, the yield is pre-
sumably very susceptible to intracellular GSH con-
centrations.
Since AAF is not metabolized to soft electro-
philes, the effect of GSH on detoxication is expected
to be of a low order. No data are available for AAF
itself, but even when the proximate carcinogen N-
OH-AAF is administered, 17% of the total biliary
conjugates are AAF-GSH adducts (60).
Paracetamol forms a soft electrophile and, as
would be expected, its GSH conjugate, 3-glutathion-
S-yl paracetamol, is very important in detoxication
and can account for 60% of the biliary metabolites
(68).
Benzo(a)pyrene produces a range of electrophiles
in vivo, including not only the soft and weak electro-
phile BP-4,5-oxide and the hard electrophile BP-7,8-
diol-9,10-oxide discussed above, but also a number of
other electrophiles including BP-9,10-diol-7,8-oxide
(40) BP-9-phenol-4,5-oxide (?) (70) and other oxides of
BP (40), apart from the stable BP-4,5-oxide. As
would be expected of a compound which is exten-
sively metabolized to a number of electrophiles,
GSH-conjugation is a major excretory pathway ac-
counting for up to 60% of the total biliary metabo-
lites (70).
In summary, the generation of a soft, but not
weak electrophile should lead to high levels of GSH
conjugation. This can be enzymic or nonenzymic;
the former is assumed to be particularly effective
and may even result in GSH depletion (35). The con-
jugation of soft but weak electrophiles requires en-
zymic intervention to bring about effective GSH
conjugation. The conjugation of hard electrophiles
also requires enzymic intervention, because these
compounds run the risk of attack by water. It might
be significant that GSH transferase B which has a
hydrophobic binding site is an effective enzyme
with those hard electrophiles which are conjugated
with GSH. So far, the two examples which have
been studied (BP-7,8-diol-9,10-oxide and aflatoxin ox-
ide) have been epoxides. Two examples of hard elec-
trophiles, the GSH conjugation of which is not cata-
lyzed, are N-sulfonyloxy derivatives of MAB and
AAF and the carbonium/nitrenium ions derived
from them.
Reference to Table 1 shows that rates of enzyme-
catalyzed GSH conjugation can vary from 62
pmole/min/mg enzyme to 4 pmole/min/mg enzyme,
i.e., they can vary over seven orders of magnitude.
It might be supposed that the lowest rates ob-
served are not significant biologically; however, in
the case of aflatoxin B1, one can calculate from the
in vitro rates of oxidation, coupled with enzyme-cat-
alyzed GSH conjugation, that the rate of AFB,-SG
formation in a 12-g rat liver should be 1.7 ,umole/min.
This is close to the observed biliary output of AFB1-
SG in rats given an intraperitoneal dose of 2 mg
AFB1, where the mean rate of excretion over 4 hr is
1.8,imole/min (48). Although the experimental sys-
tem is not ideal, the evidence is strong that a low
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enzyme rate, such as the above, can result in the
excretion of 20% (48) of the biliary metabolites as
the glutathione conjugate.
Detoxification of Oxygen
The action of the mixed function oxidation sys-
tem is associated with the release of small quanti-
ties of oxygen radicals capable of initiating lipid per-
oxidation. Such processes have been monitored both
in vivo and in vitro during xenobiotic metabolism
by the release of hydrocarbon gases (73-75). GSH is
thought to participate in the inhibition of such lipid
peroxidation processes since they are accompanied
by a loss of hepatic GSH (76) and the release of
GSSG into the bile (77). Moreover, GSH-dependent
cytosolic factors are present in rat liver which in-
hibit lipid peroxidation initiated enzymically in vitro
by ADP-Fe3 plus NADPH (78).
Our studies indicate that GSH by itself is only a
partial inhibitor of lipid peroxidation in the in vitro
system, whereas GSH plus liver cytosol yield
almost pure (complete) inhibition (Fig. 9). Extending
1/ [GSH] (mM '1)
0
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1 / [GSH Transferase B] ( MM 1)
FIGURE 9. Inhibition of lipid peroxidation by GSH and GSH
transferase B: (O) GSH alone; (e) GSH (2mM) plus purified
GSH transferase B; (0) GSH (2mM) plus dialyzed rat liver
cytosol expressed according to its content of GSH trans-
ferase B. Lipid peroxidation induced in rat liver micro-
somes by ADP-Fe3+ plus NADPH was assayed by malondi-
aldehyde formation.
the studies of Burk et al. (79), we find that purified
GSH transferase B, which displays Se-independent
GSH-peroxidase activity with lipid hydroperoxides,
is also a pure inhibitor (Fig. 9); GSH transferases A
and C do not inhibit. Using frontal elution analysis
of liver cytosol on Sephadex G-100 (Fig. 10), we have
demonstrated that the total GSH-dependent in-
hibitory activity of rat liver is accounted for (ap-
prox. 50% each) by GSH transferase B and the Se-
dependent GSH peroxidase. These enzymes pre-
sumably inhibit lipid peroxidation through reaction
with H202 and fatty acid and steroid hydroperox-
ides; however, the possibility of GSH reaction with
other active oxygen species remains to be studied.
Conclusions
The evidence is very good that GSH and GSH
transferases, both abundant in cells, provide a sys-
tem which is important in the detoxication of elec-
trophiles having the potential for cytotoxic or geno-
toxic damage.
The GSH transferases are multiple, but appear to
be related genetically and to have arisen by diver-
gence. It is assumed that a multiplicity of enzymes
is required to deal with a multiplicity of substrates;
however, it is shown that not all electrophiles, nota-
bly those derived from DAB and AAF, are sub-
strates. The net cast by the GSH transferases is by
no means perfect.
In the rat liver, an unusual GSH transferase has
evolved that appears to perform two additional
tasks associated with detoxication. This is GSH
transferase B, which in vitro evidence suggests is
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necessary for the release of heme from mitochon-
dria for use by the apoenzymes, notably cytochrome
P450, and which also appears (again from in vitro
evidence) to participate in the detoxication of by-
products of the utilization of 02 by the P450 system.
We thank the Cancer Research Campaign, of which B. K. is
a Life Fellow, for a generous grant.
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